Researchers explore the potential of tau-targeting therapies in treating Alzheimer’s disease, focusing on immunotherapies and strategies to improve their efficacy. The study dives into the complex biology of tau proteins, their modifications, and how they can be targeted to halt the progression of Alzheimer’s.
Absolutions receives FDA breakthrough designation for abdominal wall closure device
Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Absolutions Med has received breakthrough